MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Search

AdaptHealth Corp

Geschlossen

BrancheGesundheitswesen

12.66 0.64

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

12.58

Max

12.82

Schlüsselkennzahlen

By Trading Economics

Einkommen

-124M

-102M

Verkäufe

26M

846M

KGV

Branchendurchschnitt

17.527

63.808

Gewinnspanne

-11.998

Angestellte

10,900

EBITDA

-147M

24M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

-0.24% downside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

281M

1.7B

Vorheriger Eröffnungskurs

12.02

Vorheriger Schlusskurs

12.66

Nachrichtenstimmung

By Acuity

43%

57%

149 / 348 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

AdaptHealth Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Apr. 2026, 20:26 UTC

Akquisitionen, Fusionen, Übernahmen

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17. Apr. 2026, 18:15 UTC

Wichtige Nachrichtenereignisse

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17. Apr. 2026, 16:49 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17. Apr. 2026, 16:49 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17. Apr. 2026, 22:58 UTC

Ergebnisse

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17. Apr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17. Apr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Apr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17. Apr. 2026, 20:52 UTC

Ergebnisse

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17. Apr. 2026, 20:50 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

17. Apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. Apr. 2026, 20:29 UTC

Ergebnisse

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17. Apr. 2026, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

UCB to Buy Neurona Therapeutics for Up to $1.15B

17. Apr. 2026, 19:34 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Global Equities Roundup: Market Talk

17. Apr. 2026, 19:34 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17. Apr. 2026, 19:31 UTC

Market Talk
Wichtige Nachrichtenereignisse

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17. Apr. 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17. Apr. 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17. Apr. 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17. Apr. 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17. Apr. 2026, 18:57 UTC

Wichtige Nachrichtenereignisse

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17. Apr. 2026, 18:53 UTC

Akquisitionen, Fusionen, Übernahmen

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17. Apr. 2026, 18:53 UTC

Akquisitionen, Fusionen, Übernahmen

UCB 2026 Rev Guidance Unchanged

17. Apr. 2026, 18:52 UTC

Akquisitionen, Fusionen, Übernahmen

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17. Apr. 2026, 18:52 UTC

Akquisitionen, Fusionen, Übernahmen

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17. Apr. 2026, 18:14 UTC

Market Talk
Wichtige Nachrichtenereignisse

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17. Apr. 2026, 18:00 UTC

Wichtige Nachrichtenereignisse

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17. Apr. 2026, 18:00 UTC

Wichtige Nachrichtenereignisse

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17. Apr. 2026, 17:31 UTC

Market Talk
Wichtige Nachrichtenereignisse

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17. Apr. 2026, 17:26 UTC

Market Talk
Ergebnisse

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Peer-Vergleich

Kursveränderung

AdaptHealth Corp Prognose

Kursziel

By TipRanks

-0.24% Nachteil

12-Monats-Prognose

Durchschnitt 12.63 USD  -0.24%

Hoch 14 USD

Tief 9.5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AdaptHealth Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

3

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

7.95 / 8.505Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Strong Bearish Evidence

Stimmung

By Acuity

149 / 348 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über AdaptHealth Corp

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
help-icon Live chat